Pharmaceuticals
Company Overview of Hubei Xunda Pharmaceutical Co., Ltd.
Company Overview
Hubei Xunda Pharmaceutical Co., Ltd. develops anti-inflammation and pain easing drugs. It offers APIs, such as ketoprofen, 4-biphenylacetic acid/felbinac, loxoprofen sodium, fosfomycin calcium, and flurbiprofen; and intermediate products, including methyl cyclopentanone-2-carboxylate, 2-hydroxy-5-nitroacetophenone, and loxoprofen acid. The company was founded in 2002 and is based in Wuxue, China.
No.117 Yongning Avenue
Wuxue, 435400
China
Founded in 2002
Key Executives for Hubei Xunda Pharmaceutical Co., Ltd.
Hubei Xunda Pharmaceutical Co., Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Pittsburgh, PA | Research Recruiting AssociationPosted: Apr 10
- Greenfield, IN | Pace Analytical ServicesPosted: May 24
- Redlands, CA | Inventiv HealthPosted: May 24
Sponsored Financial Commentaries
Sponsored Links
To contact Hubei Xunda Pharmaceutical Co., Ltd., please visit www.xundapharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
